The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

geistlich-pharma.com

Founded Year

1851

About Geistlich Pharma

Geistlich Pharma specializes in biomaterials for the regeneration of bone, cartilage and tissue. The firm's products include Bio-Oss, Bio-Gide, Chondro-Gide, Fibro-Gide, and Orthoss.

Geistlich Pharma Headquarter Location

Bahnhofstrasse 40

Wolhusen, 6110,

Switzerland

+41 41 492 55 55

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Geistlich Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Geistlich Pharma is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,170 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

Geistlich Pharma Patents

Geistlich Pharma has filed 32 patents.

The 3 most popular patent topics include:

  • Implants (medicine)
  • Orthopedic surgical procedures
  • Skeletal system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/26/2019

4/27/2021

Periodontology, Collagens, Implants (medicine), Dentistry, Surgery

Grant

Application Date

3/26/2019

Grant Date

4/27/2021

Title

Related Topics

Periodontology, Collagens, Implants (medicine), Dentistry, Surgery

Status

Grant

Latest Geistlich Pharma News

MedTech company nets exclusive distribution deal

Mar 9, 2022

Regenerative medical devices company, Tissue Regenix Group, has signed an exclusive agreement to have its OrthoPure XT product distributed in Italy. The Leeds-based business has struck the deal with Geistlich Biomaterials Italia, a subsidiary company of Geistlich Pharma AG, a global company with a focus on regenerative products for bone, cartilage and tissue. OrthoPure XT uses Tissue Regenix’s patented dCell® technology and is the only available non-human biologic graft indicated for certain ligament reconstruction procedures. It was commercially launched in December 2020 after being awarded a CE Mark for revision of anterior cruciate ligament reconstruction procedures and reconstruction of other knee ligaments. The multi-year distribution deal covers Italy currently but also has the potential for extension to wider geographies. As part of the agreement, Geistlich has committed to advance the clinical science surrounding OrthoPure XT, which will be conducted at some of the leading institutions by clinicians in Italy. Daniel Lee, chief executive officer of Tissue Regenix, said: “We are pleased to partner with Geistlich for our commercial efforts in Italy. “Geistlich is a leader in regenerative products, so our commitments are aligned in delivering innovative products to advance patient care. “We are excited to work with them to build the clinical experience with OrthoPure XT and introduce this transformative product to the Italian medical community.” Filippo Baldini, national sales manager for Geistlich Biomaterials Italia, added: “Geistlich is excited to bring this new technology to the Italian market and serve the patient’s needs with this innovative solution.” Previous Article

Geistlich Pharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Geistlich Pharma Rank

  • When was Geistlich Pharma founded?

    Geistlich Pharma was founded in 1851.

  • Where is Geistlich Pharma's headquarters?

    Geistlich Pharma's headquarters is located at Bahnhofstrasse 40, Wolhusen.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.